Is MNKD A Good Stock To Buy Now?
After several tireless days we have finished crunching the numbers from nearly 817 13F filings issued by the elite hedge funds and other investment firms that we track at Insider...
Posts Tagged ‘NASDAQ:MNKD’
Hedge Funds Never Been Less Bullish On MannKind Corporation (MNKD)
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Is MannKind Corporation (MNKD) Going to Burn These Hedge Funds?
Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios.
Market Movers Today: AbbVie Inc (ABBV), Intel Corporation (INTC), Wynn Resorts, Limited (WYNN), and More
AbbVie, the maker of the world's best selling drug, reported fourth-quarter profit on Friday that beat Wall Street estimates on strong sales for its blockbuster drug Humira.
33 Recent Stories Telling How The Financial Markets Are Doing Today
"U.S. stocks pulled back on Tuesday after the S&P 500 and the Nasdaq Composite hit record intraday highs as a decline in healthcare stocks offset gains in technology.
40 Fresh Stories to Know How is it Going in the Financial Markets Today
"U.S. equities traded mostly lower on Friday as investors digested a tough week for retailers as well as mixed economic data.
Wondering What’s Going On in the Financial Markets Today? Check Out These 36 Stories!
"U.S. stocks wavered on Wednesday as investors digested a batch of weak corporate earnings and President Donald Trump's dismissal of his FBI chief. At 1:59 p.m.
13G Filing: James E. Flynn and Mannkind Corp (MNKD)
You can access the original SEC filing by clicking here.
Why MannKind Corporation (MNKD) Shares Popped on Friday
Shares of MannKind Corporation (NASDAQ:MNKD) initially surged sharply higher by over 20% on Friday before pulling back after Bloomberg reported that domestic retail prescriptions...
Here’s What Is Going On In The Financial Markets Today?
"Stocks rose slightly on Friday afternoon as investors parsed through a mixed employment report, a U.S. airstrike in Syria and comments from a top Federal Reserve official.
Two Biotechs To Watch This Week: Novan Inc (NOVN) And MannKind Corporation (MNKD)
Last week we saw plenty of volatility across the healthcare and biotechnology sectors, driven both by macro and micro factors.
Is MannKind Corporation (MNKD) a Good Stock to Buy?
There are several ways to beat the market, and investing in small cap stocks has historically been one of them.
5 Stocks Hedge Funds Are Betting Against Insiders
We at Insider Monkey have consistently followed hedge funds and institutional investors to help investors earn attractive returns through equity investment.
MannKind Corporation (MNKD) Stock: One Thing The Company Could Do To Return Value
MannKind Corporation (NASDAQ:MNKD) has had a rough time in the market for a couple years at this point, and for good reason.
How Does MannKind Corporation (MNKD)’s Afrezza Compare With Mealtime Insulin?
MannKind Corporation (NASDAQ:MNKD) recently presented data on its inhaled insulin candidate, Afrezza.
Why These Five Stocks Are Plummeting As Markets Rise?
U.S. stocks are up for a third consecutive trading session on Tuesday, largely driven by a marked surge in oil prices and a weakening Yen.
Why Traders Are Selling These Five Tanking Stocks?
All three major indexes are in the red on Wednesday after Apple Inc. (NASDAQ:AAPL) reported a disappointing quarter.
Here’s Why These 5 Stocks Are on the Move Today
With the NASDAQ index in the red and the S&P 500 and Dow Jones Indexes barely in the green, shares of Highpower International Inc (NASDAQ:HPJ), Chesapeake Energy Corporation (...
Why These 5 Stocks Are Posting Big Moves Today
The markets are surging on Monday, with all major U.S stock indexes, as well as oil and gold trading up. Of course, not all stocks are benefiting from the overall trend.
Why These Stocks Are Trading In Red Today
The US Stock Market is quite flattish on Monday, with major indexes posting small gains.
Why Valeant, Alibaba, Valspar, Starwood & MannKind Are All Up Today
The stock market is up slightly on Monday, with major U.S stock indexes posting gains of between 0.1% and 0.2%.
Why Are These Five Stocks Tanking Today?
With all three indices in the red today, several stocks opened lower and registered considerable losses in morning trading.
Is MannKind Corporation (MNKD) Going to Burn These Hedge Funds?
Does MannKind Corporation (NASDAQ:MNKD) represent a good buying opportunity at the moment? Let’s briefly check the hedge fund sentiment towards the company.
Why These Stocks Are Tanking Today
The decline of the U.S. stocks is continuing for the third day straight, after disappointing economic data put downward pressure on the market.
Why Are These Five Stocks on the Move Today?
With the broader market down by more than half a percent, shares of International Game Technology Ordinary Shares (NYSE:IGT), Freshpet Inc (NASDAQ:FRPT), Advance Auto Parts, ...
Why Are These Five Stocks Losing Ground on Tuesday?
The US stock market inched down on Tuesday amid concerns regarding the Chinese economy and a coming rate hike.
Why Are Investors Selling Shares of These Four Companies?
On a day where the S&P 500 is up by 0.82% and the NASDAQ is up by over 1%, shares of Green Brick Partners Inc (NASDAQ:GRBK), MannKind Corporation (NASDAQ:MNKD), Team Health Holdings...
The Future of MannKind
Shares of MannKind Corporation (NASDAQ:MNKD) got crushed on Wednesday, ending the day down by 10.07%, on the back of a research note published by Piper Jaffray analyst Joshua ...
Jason Karp Hates MannKind Corporation (MNKD), Likes NCR Corporation, Ctrip.com International, Ltd. (ADR) (CTRP)
According to CNBC, Tourbillon Capital's Jason Karp is betting on a decline of MannKind Corporation (NASDAQ:MNKD) shares.
Nektar Therapeutics (NKTR), Pfizer Inc. (PFE): What’s MannKind Corporation (MNKD) Really Worth?
This is close to the market cap that Bank of America's Steve Byrne thinks MannKind Corporation (NASDAQ:MNKD) is worth.
MannKind Corporation (MNKD), Seattle Genetics, Inc. (SGEN), Eli Lilly & Co. (LLY): A Pharmacology Primer for Biotech Investors
In pharmacology, we don't only have to consider the actions of the drug on the body.
MannKind Corporation (MNKD), Pfizer Inc. (PFE): Why Afrezza May Not Work
MannKind Corporation (NASDAQ:MNKD) has been struggling to get its inhalable insulin product Afrezza on the market; the product was sent back to the labs by the Food and Drug Administration...
MannKind Corporation (MNKD) News: Healthcare Conference, Executives, FAQ list & More
MannKind Corporation, focused on discovering, developing and commercializing treatments for diabetes, announced today that it will present at The Morgan Stanley Global Healthcare...
Hedge Funds Are Betting On Celldex Therapeutics, Inc. (CLDX)
If you were to ask many market players, hedge funds are assumed to be overrated, old investment vehicles of a forgotten age.
PDL BioPharma Inc. (PDLI): Hedge Fund and Insider Sentiment Unchanged, What Should You Do?
In the eyes of many market players, hedge funds are seen as overrated, old investment tools of a period lost to current times.
Here is What Hedge Funds and Insiders Think About Puma Biotechnology Inc (PBYI)
In today’s marketplace, there are dozens of methods market participants can use to watch the equity markets.
Will This Destroy MannKind Corporation (MNKD)?
The drug more closely mimics how the body secretes insulin after a meal to lower blood sugar, doing its job and leaving the bloodstream quickly.
Pharma News: Vivus, Inc. (VVUS), Arena Pharmaceuticals, Inc. (ARNA)’s Announcement & MannKind Corporation (MNKD)’s New Options
This week, the ratings of three Pharmaceutical stocks on Portfolio Grader are down. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).
Santarus, Inc. (SNTS): Hedge Funds Are Bullish and Insiders Are Undecided, What Should You Do?
In the financial world, there are a multitude of gauges investors can use to watch publicly traded companies. A couple of the best are hedge fund and insider trading interest.
MannKind Corporation (MNKD), EXCO Resources Inc (XCO), Riverbed Technology, Inc. (RVBD): What This $18B Scandal-Ridden Hedge Fund Has Been Buying
Today, let's look at SAC Capital Advisors, run by Steven Cohen.
MannKind Corporation (MNKD): To Infinity And Beyond?
The idea inspired me to issue my own questions about the company, using the questions as a crutch to explain my position.
NPS Pharmaceuticals, Inc. (NPSP): Hedge Funds Are Bullish and Insiders Are Undecided, What Should You Do?
In today’s marketplace, there are tons of gauges market participants can use to track their holdings.
MannKind Corporation (MNKD), Incyte Corporation (INCY): Will This Large Biotech Pop Experience Analyst Backlash?
While I do think it's possible that MannKind Corporation (NASDAQ:MNKD)'s inhaled insulin device, Afrezza, will be approved by the Food and Drug Administration, I do have serious...
What Hedge Funds Think About VIVUS, Inc. (VVUS)
In the 21st century investor’s toolkit, there are dozens of metrics investors can use to track Mr. Market.
This MannKind Corporation (MNKD) Data Is Simply Jaw-Dropping. Wow.
MannKind Corporation (NASDAQ:MNKD) has gotten one of the biggest votes of confidence we've seen from the smart money, out of the entire stock market universe and the 500+ elite...
MannKind Corporation (MNKD) Highlights: Second Tranche of Financing, Upward Trend, Price Target & More
The MannKind Corporation has announced that as per the agreement to the 1 July 2013, facility contract, between MNKD and the Deerfield Private Design Fund II.
AstraZeneca plc (ADR) (AZN), Eli Lilly & Co. (LLY), MannKind Corporation (MNKD): Three New Diabetes Drugs Possibly on the Way Soon
It's no wonder that plenty of companies are developing diabetes drugs. There are more than 370 million people with diabetes worldwide.
MannKind Corporation (MNKD), Arena Pharmaceuticals, Inc. (ARNA), VIVUS, Inc. (VVUS) – Attention Biotech Investors: Stop Looking at Share Price
After my article on MannKind Corporation (NASDAQ:MNKD) earlier this week, a reader wasn't too happy about my view that the company was overvalued given the most recent phase ...
Osiris Therapeutics, Inc. (OSIR), GlaxoSmithKline plc (ADR) (GSK), Forest Laboratories, Inc. (FRX): This Week in Biotech
With the SPDR S&P Biotech Index up 34% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Merrimack Pharmaceuticals Inc (MACK), MannKind Corporation (MNKD), Synta Pharmaceuticals Corp. (SNTA): Horrendous Health-Care Stocks This Week
While the major indexes pulled back this week, their declines paled in comparison to the huge drops experienced by a handful of health-care stocks.
